Repligen | RGEN - Stock

Aktienkurs
113.88
Täglich Wechseln
-3.73 -3.17%
Monatlich
-15.89%
Jährlich
-18.67%
Q1 Prognose
110.75




Stock Veränderung Datum
Agilent USD 1.06B 34M 2025-12
Align Technology USD 228.16M 15.59M 2025-09
Bio Techne USD 205.45M 2.26M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Bruker USD 1.2B 21.7M 2025-09
Charles River Laboratories USD 299.1M 3.45M 2025-12
Danaher USD 2.49B 185M 2025-12
Dentsply International USD 642M 44M 2025-12
Exact Sciences USD 166.2M 1.42M 2025-12
General Electric Aerospace USD 11.87B 201M 2025-12
Henry Schein USD 2B 90M 2025-12
Illumina USD 564M 26M 2025-12
Mettler Toledo International USD 387.23M 14.58M 2025-12
Myriad Genetics USD 30.6M 1000K 2025-12
OraSure Technologies USD 31.06M 2.34M 2025-12
Pacific Biosciences Of California USD 49.28M 3.87M 2025-12
Pfizer USD 11.47B 201M 2025-09
Repligen USD 170.46M 10.14M 2025-12
Revvity USD 379.5M 420K 2025-12
Standard Biotools USD 19.98M 5.44M 2025-12
Thermo Fisher Scientific USD 5.43B 320M 2025-12
Waters USD 572.37M 570K 2025-12
West Pharmaceutical Services USD 443.9M 5.9M 2025-12